PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 28 days ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
PRESS RELEASE published on 03/26/2025 at 22:05, 11 months 28 days ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax Marchés Financiers Rapports Financiers Autorités Françaises Autorités Américaines
BRIEF published on 03/24/2025 at 08:35, 11 months 30 days ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
BRIEF published on 03/24/2025 at 08:35, 11 months 30 days ago Abivax Publie ses Résultats Financiers pour 2024 Résultats Financiers Biotechnologie Recherche Et Développement Trésorerie Essais Cliniques
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 30 days ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers pour l’exercice 2024. Trésorerie de 144,2 millions d’euros au 31 décembre 2024. Perspectives financières disciplinées Résultats Financiers Biotechnologie Abivax Trésorerie Perspectives Financières
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 30 days ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
PRESS RELEASE published on 03/24/2025 at 08:30, 11 months 30 days ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers annuels pour l'Exercice 2024, montrant une trésorerie de 144,2 millions d'euros finançant les activités jusqu'au T4 2025, avec des résultats top-line attendus au T3 2025 Résultats Financiers Abivax Trésorerie Rectocolite Hémorragique Phase 3 ABTECT
BRIEF published on 03/14/2025 at 15:21, 1 year ago JP Morgan Chase Reduces Stake in ABIVAX Actions Abivax Regulation Threshold Crossing JP Morgan Chase
BRIEF published on 03/14/2025 at 15:21, 1 year ago JP Morgan Chase réduit sa participation dans ABIVAX Franchissement De Seuil Actions Abivax Réglementation JP Morgan Chase
PRESS RELEASE published on 03/14/2025 at 15:16, 1 year ago Franchissement de seuil JP Morgan Chase & Co. a déclaré détenir 4,73% du capital d'ABIVAX indirectement. Détails des actions et contrats impliqués Déclaration Actions Abivax JP Morgan Chase & Co. Franchissement Seuil
Published on 03/23/2026 at 22:40, 2 hours 14 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 2 hours 24 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 54 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 3 hours 36 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 49 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/24/2026 at 00:09, 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 2 hours 49 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 49 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 49 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 54 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 19:08, 5 hours 46 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 5 hours 46 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 6 hours 17 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 7 hours 9 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 7 hours 9 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
